Moderna
MRNA
#1251
Rank
HK$142.10 B
Marketcap
HK$358.14
Share price
-4.97%
Change (1 day)
73.36%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: HK$142.10 Billion

As of May 2026 Moderna has a market cap of HK$142.10 Billion. This makes Moderna the world's 1251th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$142.10 B49.82%
2025HK$94.85 B-20.88%
2024HK$119.88 B-59.52%
2023HK$296.14 B-45.07%
2022HK$539.16 B-32.85%
2021HK$802.96 B150.55%
2020HK$320.47 B525.11%
2019HK$51.26 B30.39%
2018HK$39.31 B

End of Day market cap according to different sources

On May 19th, 2026 the market cap of Moderna was reported to be:

HK$142.10 Billion
by Nasdaq info icon info icon
HK$142.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.336 T 2,951.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.248 T 1,482.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$2.210 T 1,455.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.42 B-96.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.32 B-83.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$6.52 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$307.79 B 116.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$80.74 B-43.18%๐Ÿ‡บ๐Ÿ‡ธ USA